CollPlant Biotechnologies (NASDAQ:CLGN) Stock Quotes, Forecast and News Summary

Q: What sector and industry does CollPlant Biotechnologies (CLGN) operate in?

CollPlant Biotechnologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CollPlant Biotechnologies Stock (NASDAQ: CLGN) stock price, news, charts, stock research, profile.

Open	$3.62
Close	-
Volume / Avg.	11.28K / 13.06K
Day Range	$3.62 - $3.80
52 Wk Range	3.31 - 6.99
Market Cap	$42.74M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	0.09%
Days to Cover	1

Recent News

CollPlant, Stratasys Initiate Study for Breast Implants

CollPlant Biotechnologies (NASDAQ: CLGN) and Stratasys Ltd.

Zacks

Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular Dystrophy.

Lisa Levin

Why CollPlant Biotechnologies Stock Is Trading Higher

CollPlant Biotechnologies Ltd (NASDAQ: CLGN) shares are trading higher Monday after the company announced it achieved a milestone in its product collaboration agreement with AbbVie Inc (NYSE:

Adam Eckert

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$3.62
Close	-
Volume / Avg.	11.28K / 13.06K
Day Range	$3.62 - $3.80
52 Wk Range	3.31 - 6.99
Market Cap	$42.74M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	0.09%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy CollPlant Biotechnologies (CLGN) stock?

You can purchase shares of CollPlant Biotechnologies (NASDAQ:CLGN) through any online brokerage.

View our list of the best stock brokerages

Who are CollPlant Biotechnologies (CLGN) competitors?

Other companies in CollPlant Biotechnologies’s space includes: Serina Therapeutics (AMEX:SER), Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), Gain Therapeutics (NASDAQ:GANX) and OncoCyte (NASDAQ:OCX).

What is the forecast, or price target, for CollPlant Biotechnologies (CLGN) stock?

CollPlant Biotechnologies has a consensus price target of $15.44.

What is the current price for CollPlant Biotechnologies (CLGN)?

The stock price for CollPlant Biotechnologies (NASDAQ: CLGN) is $3.731 last updated December 18, 2024 at 1:12 PM EST.

Does CollPlant Biotechnologies (CLGN) pay a dividend?

There are no upcoming dividends for CollPlant Biotechnologies.

When is CollPlant Biotechnologies (NASDAQ:CLGN) reporting earnings?

CollPlant Biotechnologies’s Q3 earnings are confirmed for Wednesday, November 27, 2024.

Is CollPlant Biotechnologies (CLGN) going to split?

There is no upcoming split for CollPlant Biotechnologies.

What sector and industry does CollPlant Biotechnologies (CLGN) operate in?

CollPlant Biotechnologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

CollPlant Biotechnologies

CollPlant Biotechnologies (CLGN) Forecast